Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular mutations in thyroid carcinogenesis.

Jennifer L Hunt1

  • 1Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

American Journal of Clinical Pathology
|October 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Some Considerations on the WHO Histological Classification of Laryngeal Neoplasms.

Advances in therapy·2019
Same author

Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies.

Advances in anatomic pathology·2019
Same author

Salivary myoepithelial cells: an addendum.

Ultrastructural pathology·2018
Same author

Data Set for the Reporting of Nodal Excisions and Neck Dissection Specimens for Head and Neck Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

Archives of pathology & laboratory medicine·2018
Same author

Structural biology of intraepithelial neuroendocrine cells in the larynx: Literature review.

Pathology, research and practice·2018
Same author

Surgical margins in head and neck cancer: Intra- and postoperative considerations.

Auris, nasus, larynx·2018
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
Same journal

Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

American journal of clinical pathology·2026
See all related articles

Molecular mutations in thyroid carcinomas, including oncogene and tumor suppressor gene events, drive cancer development. This review examines these genetic changes and current diagnostic testing for thyroid tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Thyroid carcinomas exhibit well-characterized molecular mutations, encompassing both germline and somatic genetic alterations.
  • These mutations are broadly classified into oncogene mutations and tumor suppressor gene mutations, crucial for tumorigenesis.

Purpose of the Study:

  • To review the molecular mutations characteristic of various thyroid tumors.
  • To examine the current landscape of diagnostic testing for thyroid tumors.

Main Methods:

  • Literature review of molecular alterations in thyroid carcinomas.
  • Analysis of current diagnostic methodologies for thyroid tumor molecular profiling.

Main Results:

  • Detailed discussion of specific molecular mutations linked to thyroid tumorigenesis.

Related Experiment Videos

  • Overview of diagnostic approaches for identifying these genetic events.

    • Conclusions:

    • Understanding molecular mutations is key to comprehending thyroid cancer development.
    • Current diagnostic practices are evolving to incorporate molecular testing for improved thyroid tumor management.